NURECA
Back to All Ratios
|
NURECA Last 5 Year Working Capital/Sales History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Working Capital/Sales(x) | 0.55 | 0.66 | 1.39 | 1.39 | 4.45 |
What is the latest Working Capital/Sales ratio of NURECA ?
Year | Working Capital/Sales |
---|---|
Mar2024 | 0.55 |
Mar2023 | 0.66 |
Mar2022 | 1.39 |
Mar2021 | 1.39 |
Mar2020 | 4.45 |
How is Working Capital/Sales of NURECA Trending?
Years | Working Capital/Sales | % Change | |
---|---|---|---|
Mar2024 | 0.55 | -16.67 | |
Mar2023 | 0.66 | -52.52 | |
Mar2022 | 1.39 | 0.00 | |
Mar2021 | 1.39 | -68.76 | |
Mar2020 | 4.45 | - |
Other Financial Ratios of NURECA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Working Capital/Sales ratio of peers of NURECA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NURECA | ₹407.9 Cr | 23.4% | 42.2% | -6.6% | Stock Analytics | |
POLY MEDICURE | ₹25,452.0 Cr | -3.3% | -7.8% | 71% | Stock Analytics | |
PREVEST DENPRO | ₹755.7 Cr | 4% | 7.7% | 41% | Stock Analytics |
NURECA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NURECA | 23.4% |
42.2% |
-6.6% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses